alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › day

day

3 studies tagged day, dated 2021-02-08 to 2024-09-13. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. P-tau217 and other blood biomarkers of dementia: variation with time of day 2024-09-13
  2. Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate 2022-01-01
  3. Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A2A Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS 2021-02-08

Studies

3 studies carry this tag.

Date range

2021 to 2024

Top journals

  • Molecules (Basel, Switzerland) 1
  • The journal of prevention of Alzheimer's disease 1
  • Translational psychiatry 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. P-tau217 and other blood biomarkers of dementia: variation with time of day

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Translational psychiatry 2024-09-13 Biomarkers

    Plasma biomarkers of dementia, including phosphorylated tau (p-tau217), offer promise as tools for diagnosis, stratification for clinical trials, monitoring disease progression, and assessing the success of interventions in those living with Alzheimer's disease.

  2. Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate

    ✓ Peer-reviewed alzhub usefulness score 74 out of 100. The journal of prevention of Alzheimer's disease 2022-01-01 Drug development

    If the primary end points are met, the data will provide confirmatory evidence of the clinical and biomarker benefits of hydromethylthionine mesylate in minimal to moderate AD.

  3. Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A2A Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Molecules (Basel, Switzerland) 2021-02-08 Drug development

    The first finding is the positive results of the docking study with the crystal structures of A 2A adenosine (A2AAR) and acetylcholine esterase (AChE) receptors.

All topic tags with their study counts